Intercept Pharmaceuticals, Inc. (ICPT): Price and Financial Metrics

ICPT POWR Grades

• Value is the dimension where ICPT ranks best; there it ranks ahead of 95.8% of US stocks.
• ICPT's strongest trending metric is Growth; it's been moving up over the last 177 days.
• ICPT ranks lowest in Stability; there it ranks in the 18th percentile.

ICPT Stock Summary

• Equity multiplier, or assets relative to shareholders' equity, comes in at -2.55 for INTERCEPT PHARMACEUTICALS INC; that's greater than it is for only 4.42% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, INTERCEPT PHARMACEUTICALS INC is reporting a growth rate of -529.51%; that's higher than just 3.28% of US stocks.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ICPT comes in at 33.03% -- higher than that of 95.6% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to INTERCEPT PHARMACEUTICALS INC are SRDX, FKWL, KLIC, ESPR, and ONTX.
• ICPT's SEC filings can be seen here. And to visit INTERCEPT PHARMACEUTICALS INC's official web site, go to www.interceptpharma.com.

ICPT Valuation Summary

• In comparison to the median Healthcare stock, ICPT's price/earnings ratio is 83.71% lower, now standing at 3.6.
• ICPT's price/sales ratio has moved down 97.8 over the prior 125 months.

Below are key valuation metrics over time for ICPT.

ICPT Growth Metrics

The year over year net cashflow from operations growth rate now stands at 94.35%.
• Its year over year cash and equivalents growth rate is now at -40.75%.
• Its 5 year net income to common stockholders growth rate is now at 7.63%.

Over the past 33 months, ICPT's revenue has gone up $78,329,000.

The table below shows ICPT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	330.331	-18.121	206.361
2022-06-30	345.57	3.106	-64.724
2022-03-31	370.389	-7.113	-68.29
2021-12-31	363.468	-41.639	-91.426
2021-09-30	354.332	-61.467	-107.293
2021-06-30	341.026	-106.584	-170.13

ICPT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ICPT has a Quality Grade of B, ranking ahead of 77.14% of graded US stocks.
• ICPT's asset turnover comes in at 0.66 -- ranking 47th of 682 Pharmaceutical Products stocks.
• GBT, AVDL, and SYRS are the stocks whose asset turnover ratios are most correlated with ICPT.

The table below shows ICPT's key quality metrics over time.